Check out ATRS website, and go to investor relations. Listen to the latest webcast...from May 16 at Bank of America conference. At the end of the presentation, the moderator asks ATRS CEO specifically about Copaxone. CEO Watton seemed strangely prepared for the question...
I'd wager Teva and ATRS are working together on NTE for Copaxone combo with ATRS injector device...
ATRS investors speculating same, especially on investors hub atrs message board...
well, clearly lots of people agree...given price and volume over last couple of weeks...
I quite luckily stumbled onto this and bought about 7000 at $1...just looked like it had turned...
But I sold about 1/3 after 70% run...figured no tree grows non-stop to the sky...but maybe this one does?!?!lol
"will not see the light of day for years to come"
huh?
someone state plainly what he means by this, please??? thanks...
told ya...run, maybe you can catch up with this train...but you better hurry...
frank...one more point about ATRS...
Fmurph1 (yahoo message board poster) was a long time bull and poster on CLNT board...He is long time and current holder of ATRS..
Yo, Frank.
Congrats on your investments here and CLDX. I mentioned ATRS to you last year (was AIS, changed symbol with Nasdaq listing)
Their story isn't a secret. The big date is October 14, PDUFA for Otrexup...brand name for methotrexate injector. Indication is for rheumatoid arthritis.
Check company website for recent conference calls. Latest was yesterday. Seeking alpha articles lay out future revenue projections.
Still chance to get in at reasonable prices, imo.
GL
true
I'm not. Selling such a small percentage of shares is a non-issue.
strike "they'll" replace with "there'll" or "there will"
Its usually not a good idea to trust anyone on an anonymous message board. But I recommend to any new readers here to make an exception with Fmurph1.
If you don't know him...let me say this...
I first encountered him posting similar thoughts about a diagnostic company called Clarient (CLNT I think). You won't find that company because it was bought out at a significant premium by GE.
Fmurph knows what he's talking about. You'd do well to listen and heed his post.
With such good prospects, I think the odds are ATRS gets bought by big pharma, leaving us with a good payout rather than the mega profit. But who knows? Perhaps we can be the next JAZZ or ISRG...
Look closely at the JAZZ chart...as it made its big run. You'll need some strong intestinal fortitude to hold ATRS if it makes a similar run. For Jazz, it wasn't up in a straight line. You'll need a plan...perhaps some planned sales at certain price points...or hold for a definite number of years no matter what (as long as company is performing as planned)... But they'll be shakeout attempts...
Anyways...drifting off topic...conclusion...Fmurph1 is not new to the rodeo...he's has experience and proven success...
Sentiment: Strong Buy
All the expressions of displeasure about a possible buyout of ATRS won't make a difference, of course.
But the possibility is a strong reason to get on the train now, instead of trying to wait for a lower price.
25 or 6 to 4,
Here's a clue for you...knowing the facts about a company is part of what's needed to make money in the market.
The other part is buying low and selling high. Or some prefer to buy high and sell higher. Actually, the latter is the way to go if you factor in the time value of money.
A price chart is a picture of supply and demand. You'll notice the price crossed below the 150 ma in mid January (some prefer to use the 200). That signaled the stock was in a confirmed downtrend. Time to get out, not time to make new purchases...
Stock price has now crossed above the 150 (200 also) signals an uptrend. Since the long term moving averages are still not yet up-sloping, not as strong a signal as it could be...I'd expect some re-tests.
Just because you may not understand these tools, doesn't mean they're not very useful. Combining TA with FA I believe gives the best $$ making results...
Price and volume
pps on or about april 25, the 20 ma crossed the 50 ma (bullish).
Notice while stock trended upward in 2011 and 2012 it traded well above the 200 ma, and the 200 ma sloped upward.
To confirm an uptrend, from TA point of view, look for the 200 ma to flatten out then begin to slope upward. Also, in a matter of days, the 20 ma should cross over the 200 ma.
Could use the 200 ma as a stop (for traders) or a point to add shares (investors).
Just my amateur TA thoughts, for your entertainment and/or edification.
Sentiment: Strong Buy
PS watch the 200 DMA
Not too worried about it. This stock has catalysts, including a very important one.
We'll soon be talking about 4 as support, not resistance.
Buy while you still can...or buy higher.
Sentiment: Strong Buy
just making fun of the bombastic bashers who show up here to try to suppress price runs...just entertainment...
1. Powerful bull market...don't fight the trend
2. Mucho warrant holders want this as much above 3.85 (correct me those who are well-informed on this one) by end of June.
3. Huge catalyst in October 14 PDUFA gets closer every day
4. Large cash position and no immediate risk of dilution
5. On-going revenues covering operations.
6. Deep, diverse, low risk pipeline.
Yeah, seems like obvious short-sale candidate...
Sentiment: Strong Buy
#$%$, loko. You insult the "great-one" in your question, and you expect a respectful answer? Of course you don't. You're kind of like Sergio...I'm great...but I'm the victim...
You play a great research game, but try doing something practical like advising how all that raw information will affect the stock price, and when it will have an effect.
whatever...we'll survive just fine without you, if choose to leave.
10 day crossed over on May 6/7.
20 day sma crossed 50 day sma today.